review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1515/REVNEURO.1998.9.4.265 |
P698 | PubMed publication ID | 9886141 |
P50 | author | Bjørn Bjorvatn | Q17057497 |
Reidun Ursin | Q76450575 | ||
P2860 | cites work | Dose-dependent effects of the 5-HT1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat. | Q33884340 |
The 5-HT1A antagonist (-)-alprenolol fails to modify sleep or zimeldine-induced sleep-waking effects in rats | Q34540032 | ||
Cholinergic nucleus basalis neurons display the capacity for rhythmic bursting activity mediated by low-threshold calcium spikes | Q35661947 | ||
5-HT1 receptors and behavior | Q35942139 | ||
Serotonin hyperpolarizes cholinergic low-threshold burst neurons in the rat laterodorsal tegmental nucleus in vitro | Q36797732 | ||
Effect of antipsychotic drugs on the firing of dorsal raphe cells. I. Role of adrenergic system | Q39117180 | ||
Biogenic amines and the states of sleep | Q39890680 | ||
Raphe unit activity in freely moving cats: Correlation with level of behavioral arousal | Q40215755 | ||
Current advances and trends in the treatment of depression | Q41028584 | ||
5-HT receptor classification and nomenclature: towards a harmonization with the human genome | Q41533296 | ||
Short-term effects of fluoxetine and trifluoromethylphenylpiperazine on electroencephalographic sleep in the rat. | Q42216690 | ||
Unit activity of rat basal forebrain neurons: relationship to cortical activity | Q42438615 | ||
Pharmacological and immunohistochemical evidence for serotonergic modulation of cholinergic nucleus basalis neurons. | Q42503518 | ||
Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex | Q42520623 | ||
Ipsapirone, a 5-HT1A agonist, suppresses REM sleep equally in unmedicated depressed patients and normal controls | Q44513254 | ||
Behavioral, sleep-waking and EEG power spectral effects following the two specific 5-HT uptake inhibitors zimeldine and alaproclate in cats | Q44741141 | ||
Effects of the selective 5-hydroxytryptamine uptake inhibitors paroxetine and zimeldine on EEG sleep and waking stages in the rat. | Q45235021 | ||
5-HT1-like receptor agonists enhance wakefulness | Q46118679 | ||
The influence of ipsapirone, a 5-HT1A agonist, on sleep patterns of healthy subjects | Q46360645 | ||
Human sleep EEG following the 5-HT1A antagonist pindolol: possible disinhibition of raphe neuron activity | Q46444110 | ||
Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep: an in vitro electrophysiological study | Q46902344 | ||
Serotonergic synaptic input to cholinergic neurons in the rat mesopontine tegmentum | Q48106896 | ||
Depletion of brain serotonin by 5,7-DHT: effects on the 8-OH-DPAT-induced changes of sleep and waking in the rat. | Q48119235 | ||
The effects of 5-hydroxytryptophan andl-tryptophan on wakefulness and sleep patterns in the cat | Q48392588 | ||
Dorsal raphe neurons: depression of firing during sleep in cats | Q48406686 | ||
On-line detection of extracellular levels of serotonin in dorsal raphe nucleus and frontal cortex over the sleep/wake cycle in the freely moving rat. | Q48522681 | ||
Fluoxetine decreases brain temperature and REM sleep in Syrian hamsters | Q48548849 | ||
Sleep/waking effects of a selective 5-HT1A receptor agonist given systemically as well as perfused in the dorsal raphe nucleus in rats | Q48559536 | ||
l-Tryptophan: Effects on daytime sleep latency and the waking EEG | Q48560097 | ||
Low brain uptake of L-[11C]5-hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers | Q48713746 | ||
The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptors | Q48716431 | ||
Diurnal differences in L-tryptophan sleep and temperature effects in the rat. | Q48829027 | ||
Central administration of two 5-HT receptor agonists: effect on REM sleep initiation and PGO waves | Q48834569 | ||
Effects of the selective 5-HT1B agonist, CGS 12066B, on sleep/waking stages and EEG power spectrum in rats | Q48840755 | ||
Stereoselective antagonism by the pindolol enantiomers of 8-OH-DPAT-induced changes of sleep and wakefulness | Q48846306 | ||
Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats | Q48857389 | ||
The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat. | Q48858788 | ||
Effects of ipsapirone, a 5-HT1A agonist, on sleep/wakefulness cycles: probable post-synaptic action | Q48867459 | ||
Functional activity of 5-HT2 receptors in the modulation of the sleep/wakefulness states | Q48883898 | ||
The effect of 3-h and 6-h sleep deprivation on sleep and EEG spectra of the rat. | Q48930654 | ||
Increased waking as well as increased synchronization following administration of selective 5-HT uptake inhibitors to rats | Q48939885 | ||
Suppressant effects of selective 5-HT2 antagonists on rapid eye movement sleep in rats | Q48943475 | ||
Increased sleep following intracerebroventricular injection of the delta sleep-inducing peptide in rats | Q49104588 | ||
Sleep and EEG power spectrum effects of the 5-HT1A antagonist NAN-190 alone and in combination with citalopram | Q49132874 | ||
The effect of para-chlorophenylalanine on the sleep of cats | Q49135347 | ||
5-HT antagonists suppress sleep and delay its restoration after 5-HTP in p-chlorophenylalanine-pretreated cats | Q49135702 | ||
Differential effect of para-chlorophenylalanine on the two slow wave sleep stages in the cat. | Q54625119 | ||
P433 | issue | 4 | |
P304 | page(s) | 265-273 | |
P577 | publication date | 1998-01-01 | |
P1433 | published in | Reviews in the Neurosciences | Q15750651 |
P1476 | title | Changes in sleep and wakefulness following 5-HT1A ligands given systemically and locally in different brain regions | |
P478 | volume | 9 |